Sculptor Capital’s Precigen PGEN Stock Holding History

Sculptor Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-39,000	Closed	-$214K	–	277
2019 Q4	$214K	Hold	39,000	–	–	﹤0.01%	250
2019 Q3	$223K	Hold	39,000	–	–	﹤0.01%	276
2019 Q2	$299K	Buy	+39,000	New	+$210K	﹤0.01%	253
2019 Q1	–	Sell	-27,900	Closed	-$182K	–	254
2018 Q4	$182K	Hold	27,900	–	–	﹤0.01%	218
2018 Q3	$480K	Sell	27,900 -272,600	-91%	-$4.05M	﹤0.01%	216
2018 Q2	$4.19M	Buy	+300,500	New	+$5.08M	0.02%	119
2017 Q4	–	Sell	-123,200	Closed	-$2.34M	–	129
2017 Q3	$2.34M	Hold	123,200	–	–	0.01%	211
2017 Q2	$2.97M	Hold	123,200	–	–	0.02%	206
2017 Q1	$2.44M	Buy	+123,200	New	+$2.75M	0.01%	204
2016 Q3	–	Sell	-47,221	Closed	-$1.15M	–	368
2016 Q2	$1.15M	Hold	47,221	–	–	0.01%	279
2016 Q1	$1.59M	Buy	+47,221	New	+$1.49M	0.01%	291

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sculptor Capital's PGEN Position: Q1 2021 in Review

Sculptor Capital sold out of Precigen (PGEN) in Q1 2021, closing a stake of 77,258 shares — an estimated $788K sold.

Sculptor Capital first reported a position in PGEN in Q1 2016 and held it in 16 quarters. The position peaked at $4.19M in Q2 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2021.

Sculptor Capital reported no remaining Precigen position as of Q1 2021 after selling out during the quarter.
Sculptor Capital sold 77,258 Precigen shares in Q1 2021, an estimated $788K.
Sculptor Capital first reported a position in Precigen in Q1 2016 and held it in 16 quarters.
Sculptor Capital's Precigen position peaked at $4.19M in Q2 2018.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2021.

Based on Sculptor Capital's 13F filing for Q1 2021, filed 14 May 2021.